A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based Regimens

A Population Pharmacokinetic/Pharmacodynamic Model Predicts Favorable HDL Cholesterol Changes Over the First 5 Years in Children Treated With Current Efavirenz-Based Regimens

© 2016, The American College of Clinical Pharmacology Efavirenz use is associated with changes in cholesterol concentrations, but it is unclear whether this effect is related to drug concentrations. Using efavirenz and cholesterol plasma concentrations measured in 87 antiretroviral-naive children in...

Full description

Saved in:
Bibliographic Details
Main Authors: Nontiya Homkham, Tim R. Cressey, Lily Ingsrisawang, Naïm Bouazza, Chaiwat Ngampiyaskul, Suchat Hongsiriwon, Sakulrat Srirojana, Suparat Kanjanavanit, Sorakij Bhakeecheep, Sophie Le Coeur, Nicolas Salvadori, Jean Marc Treluyer, Gonzague Jourdain, Saik Urien
Format: Journal
Published: 2018
Subjects:
Medicine
Pharmacology, Toxicology and Pharmaceutics
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84959423363&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/56250
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University

Internet

https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84959423363&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/56250

Similar Items